Artificial Intelligence in Medicine

Objective

Partnering  & Commercialization of AIM – Artificial Intelligence in Medicine program from Cedars Sinai. Cedars is seeking a distribution partnership to license AIM in Asia
Target markets

• China
• India
• Israel
• Korea
• Japan

Technology

AIM is a software suite that allows for processing and analysis of 3D images of the heart leading to measurements that help cardiologists the state & behavior of the heart.

• Reconstruction & Reorientation
• Perfusion & Function Quantification
• Automated Reporting

AIM algorithms have been developed to:

• Take raw digital data output from CT/PET/SPECT/GAMMA camera among others
• Take tomographic images of the heart
• Analyze the dynamic functioning of the heart
• Be compatible across imaging devices (GE, Siemens, Phillips etc) in nuclear medicine/cardiology facilities

AIM Features

• QGS+QPS – Quantitative Gated + Perfusion SPECT
• QBS – Quantitative Blood Pool SPECT
• QPET – Quantitative PET
• ARG – Automated Report Generator
• AutoRecon
• MoCo – Motion Correction

Partnering Advantages

• Engage over read-to-deploy, validated platform – considered the gold standard in nuclear cardiology
• Globally recognized software & algorithm with high acceptance in the medical community
• Increasing consumer base with new nuclear medicine/cardiology centres each year

For partnering and additional information, please write to nikhil.dhar@skyquestt.com